2021 annual financial data
Virax Biolabs Group 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -476.65%.
Operating income was -644,540 USD and net income was -650,984 USD.
Operating cash flow was -590,186 USD.
Get free Virax Biolabs Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 123,820 USD
- Operating income
- -644,540 USD
- Net income
- -650,984 USD
- Operating cash flow
- -590,186 USD